Definitive Contract 75N91019C00044

Award Date 9/16/19
Potential Completion Date 8/15/20
Potential Value $354K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21205, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
7
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This SBIR Phase I contract award of $399,870 to Oncospace Inc. will fund research and development of a software tool for standardizing radiotherapy treatment plans to support artificial intelligence validation. The contract responds to National Institutes of Health National Cancer Institute SBIR Topic 454 and will take place over one year in Baltimore, Maryland. It was awarded under the NIH/CDC SBIR solicitation seeking innovative solutions across over 125 topics related to cancer treatment,...
This is a $455,000 firm fixed price contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The contract was awarded to Mrimath LLC, a small disadvantaged, woman-owned limited liability company, for a Small Business Innovation Research (SBIR) Phase I project related to Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. The contract has a...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
This is a $455,000 firm fixed-price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Carina Medical LLC, a minority-owned small business. The contract supports research and development of artificial intelligence (AI)-aided imaging technologies for cancer prevention, diagnosis, and monitoring. This work aligns with the NCI's mission and the SBIR program's goals of stimulating...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Phenomapper, LLC, a minority-owned, self-certified small disadvantaged business located in San Jose, California. The $398,952.00 firm-fixed-price contract was awarded on September 16, 2020, with a completion date of September 15, 2021. The contract is for the development of artificial intelligence-aided imaging technology...
This is a $400,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH). The contract was awarded to Veloxai LLC, a self-certified small disadvantaged business, to develop an automatic treatment planning system for high-dose rate brachytherapy for cervical cancer in low-resource settings. The contract was set aside for total small businesses and has a completion date of September 14,...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Intelligent Automation, LLC, a small business. The contract is for the development of a Mobile PRO-CTCAE Administration System for Post-Radiation Toxicities, with a potential value of $224,995.00. The contract is a Firm Fixed Price Definitive Contract. Intelligent Automation has previously received SBIR Phase III awards from the U.S. Air Force for...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $2 million firm fixed price definitive contract to Carina Medical LLC as a total small business set aside. The contract is for Fiscal Year 2023 Small Business Innovation Research Topic 402 Phase II efforts to enhance the performance of artificial intelligence for lymph node detection, segmentation and measurements in multi-modality medical imaging, and to develop additional...
This $2,399,183 firm-fixed-price SBIR Phase I contract was awarded by the National Cancer Institute (NCI) to Radiologics, Inc., a small business, to conduct research and development on cancer imaging tools and image de-identification software. The contract is part of the NCI's SBIR program, which aims to stimulate technological innovation and increase private sector commercialization of innovations derived from federal R&D. The contract has a period of performance through January 2024 and is...
This is a $398,604.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded to Infotech Soft, Inc. (a woman-owned for-profit organization) by the National Cancer Institute. The contract is for the development of quantitative imaging software tools to assist with cancer diagnosis and treatment planning. The contract is a definitive, firm fixed-price agreement, indicating a well-defined scope of work. This SBIR award is part of the National Cancer Institute's efforts to...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $354,415.00 Firm Fixed Price contract to Oncospace Inc., a Baltimore-based small business, to develop artificial intelligence (AI) tools to understand and duplicate expert radiation therapy planning for prostate cancer. This contract is part of the Small Business Innovation Research (SBIR) program and builds upon prior SBIR and National Science Foundation awards to Oncospace Inc. totaling over $3.4 million for developing AI and data analytics solutions to optimize radiation therapy outcomes, including treatment planning standardization and quality assurance. The contract is focused on creating AI models to automate and standardize radiation therapy planning for prostate cancer.

Generated 3/21/24, 9:14 PM